Terumo Ends Boston Scientific Deal to Start Urology Unit

Terumo Corp., Asia’s biggest maker of medical devices, plans to end a urology partnership with Boston Scientific Corp. in the U.S. and create its own sales, marketing and distribution unit for the products in April.

Creating the urology unit will provide better access to a U.S. market estimated to generate $2.3 billion in sales by 2016, the Tokyo-based company said in a statement today. The Terumo Interventional Systems unit sells devices including guidewires and catheters that give doctors access to the heart and peripheral blood vessels to treat disease.